Anticipating Ovarian Tissue Cryopreservation in the Health-Care Marketplace: A Willingness to Pay Assessment
The developing fertility preservation technologies offer new options, but not without a cost. As the technologies become integrated into the healthcare marketplace, cost will become an even greater issue. A critical question in this discussion is whether young women and their parents would be willing to pay for insurance to cover the cost of these procedures.
KeywordsContingent Valuation Fertility Preservation Ovarian Tissue Cryopreservation Fertility Preservation Option Embryo Banking
This research was supported by the Oncofertility Consortium NIH 8UL1DE019587, 5RL1HD058296.
- 4.Kenkel D, Berger M, Blomquist G Contingent valuation of health. In: Tolley G, Kenkel D, Fabian R, Eds. Valuing health for policy. Chicago: University of Chicago Press; 1994:72–104.Google Scholar
- 5.Becker G. et al. Value of Life Near Its End and Terminal Care. NBER Working Paper 13333; 2007. Available at http://www.nber.org/papers/w13333. Accessed October 20, 2009.